chr5-10286492-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138809.4(CMBL):c.328A>T(p.Ile110Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138809.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMBL | NM_138809.4 | c.328A>T | p.Ile110Phe | missense_variant | 4/6 | ENST00000296658.4 | NP_620164.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMBL | ENST00000296658.4 | c.328A>T | p.Ile110Phe | missense_variant | 4/6 | 1 | NM_138809.4 | ENSP00000296658.3 | ||
CMBL | ENST00000506821.1 | n.582A>T | non_coding_transcript_exon_variant | 4/4 | 2 | |||||
CMBL | ENST00000510532.5 | n.396A>T | non_coding_transcript_exon_variant | 4/5 | 3 | |||||
CMBL | ENST00000511963.5 | n.436A>T | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251022Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135694
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461602Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727100
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.328A>T (p.I110F) alteration is located in exon 4 (coding exon 3) of the CMBL gene. This alteration results from a A to T substitution at nucleotide position 328, causing the isoleucine (I) at amino acid position 110 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at